Transdermal Drug Delivery Devices Market

DelveInsight’s ‘Transdermal Drug Delivery Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Transdermal Drug Delivery Devices and the historical and forecasted Transdermal Drug Delivery Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Transdermal Drug Delivery Devices market report provides an overview of Transdermal Drug Delivery Devices , reasons to get Transdermal Drug Delivery Devices as well as its advantages and limitations. Additionally, the report provides insight on the Transdermal Drug Delivery Devices market share of the individual Transdermal Drug Delivery Devices devices, current and forecasted Transdermal Drug Delivery Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Transdermal Drug Delivery Devices Overview

Transdermal drug delivery systems are an alternative to the intravascular, subcutaneous, and transmucosal oral routes through which the drugs are delivered for therapeutic use through the skin. Market growth is expected to be driven by an increase in the geriatric population and an upsurge in the number of patients with chronic disorders. In addition, market growth is boosted by the increase in the adoption of third-generation transdermal drug delivery systems. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. However, market growth is expected to be impeded by the disadvantages of these delivery systems, such as irritation at the site of application and edema.

Study Period: 2017–2025

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).


Transdermal Drug Delivery Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Transdermal Drug Delivery Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.


Transdermal Drug Delivery Devices : Market Analysis

This segment illustrates the market of Transdermal Drug Delivery Devices across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Transdermal Drug Delivery Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Transdermal Drug Delivery Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Transdermal Drug Delivery Devices , explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Transdermal Drug Delivery Devices is provided, which will have an impact on the future market of Transdermal Drug Delivery Devices .
  • A detailed review of Transdermal Drug Delivery Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Transdermal Drug Delivery Devices market.

Report Highlights

  • The report covers descriptive overview of the Transdermal Drug Delivery Devices , explaining its applications, working mechanism, etc.
  • The report provides an insight into the patient population eligible for Transdermal Drug Delivery Devices in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Transdermal Drug Delivery Devices market.
  • The report also reviews the detailed global historical and forecasted Transdermal Drug Delivery Devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Transdermal Drug Delivery Devices market.


Transdermal Drug Delivery Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • Patient pool
  • Market Size


Transdermal Drug Delivery Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Transdermal Drug Delivery Devices market share (%) distribution in 2017 and how it will look like in 2025?
  • What will be the Transdermal Drug Delivery Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2017–2025)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Transdermal Drug Delivery Devices market Size during the forecast period (2017–2025)?
  • At what CAGR, the Transdermal Drug Delivery Devices market is expected to grow in 7mm during the forecast period (2017–2025)?
  • What will be the Transdermal Drug Delivery Devices market outlook across the 7mm during the forecast period (2017–2025)?
  • What will be the Transdermal Drug Delivery Devices market growth till 2025 and what will be the resultant market size in the year 2025?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Competitive Landscape:

  • What are the current devices available in the Transdermal Drug Delivery Devices market?
  • What is the Transdermal Drug Delivery Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Transdermal Drug Delivery Devices ?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Transdermal Drug Delivery Devices ?
  • What are the key designations that have been granted for the current Transdermal Drug Delivery Devices ?
  • What are the global historical and forecasted market of Transdermal Drug Delivery Devices ?

 

1. Key Insights

2. Executive Summary of Transdermal Drug Delivery Devices

3. Transdermal Drug Delivery Devices : Background and Overview

3.1. Introduction

4. Company Profiles

4.1. Company A

4.1.1. Company Overview

4.1.2 Product Portfolio

4.1.2.1 Product description

4.1.2.2 Regulatory Milestones

4.1.2.3 Research and Development

4.1.2.4 Product Development Activities

4.2. Company B

4.2.1.Company Overview

4.2.2 Product Portfolio

4.2.2.1 Product description

4.2.2.2 Regulatory Milestones

4.2.2.3 Research and Development

4.2.2.4 Product Development Activities

Products detail in the report…

5 Transdermal Drug Delivery Devices : Competitive Analysis

6. Transdermal Drug Delivery Devices Devices: Market Analysis

6.1. Transdermal Drug Delivery Devices : Market Analysis in the 7MM (2017–2025)

 6.1.1. Transdermal Drug Delivery Devices : Market Analysis in the 7MM by type (2017–2025)

 6.1.2. Transdermal Drug Delivery Devices : Market Analysis in the 7MM by application (2017–2025)

 6.1.3. Transdermal Drug Delivery Devices : Market Analysis in the 7MM by end user (2017–2025)

6.2. Transdermal Drug Delivery Devices : United States Market Analysis (2017–2025)

 6.2.1. Transdermal Drug Delivery Devices : Market Analysis in the US by type (2017-2025)

 6.2.2. Transdermal Drug Delivery Devices : Market Analysis in the US by application (2017-2025)

 6.2.3. Transdermal Drug Delivery Devices : Market Analysis in the US by end user (2017-2025)

6.3. Transdermal Drug Delivery Devices : Germany Market Analysis (2017–2025)

  6.3.1. Transdermal Drug Delivery Devices : Market Analysis in Germany by type (2017-2025)

 6.3.2. Transdermal Drug Delivery Devices : Market Analysis in Germany by application (2017-2025)

 6.3.3. Transdermal Drug Delivery Devices : Market Analysis in Germany by end user (2017-2025)

6.4. Transdermal Drug Delivery Devices : France Market Analysis (2017–2025)

 6.3.1. Transdermal Drug Delivery Devices : Market Analysis in France by type (2017-2025)

 6.3.2. Transdermal Drug Delivery Devices : Market Analysis in France by application (2017-2025)

 6.3.3. Transdermal Drug Delivery Devices : Market Analysis in France by end user (2017-2025)

6.5. Transdermal Drug Delivery Devices : Italy Market Analysis (2017–2025)

  6.5.1. Transdermal Drug Delivery Devices : Market Analysis in Italy by type (2017-2025)

 6.5.2. Transdermal Drug Delivery Devices : Market Analysis in Italy by application (2017-2025)

 6.5.3. Transdermal Drug Delivery Devices : Market Analysis in Italy by end user (2017-2025)

6.6. Transdermal Drug Delivery Devices : Spain Market Analysis (2017–2025)

 6.6.1. Transdermal Drug Delivery Devices : Market Analysis in Spain by type (2017-2025)

 6.6.2. Transdermal Drug Delivery Devices : Market Analysis in Spain by application (2017-2025)

 6.6.3. Transdermal Drug Delivery Devices : Market Analysis in Spain by end user (2017-2025)

6.7. Transdermal Drug Delivery Devices : United Kingdom Market Analysis (2017–2025)

 6.7.1. Transdermal Drug Delivery Devices : Market Analysis in the UK by type (2017-2025)

 6.7.2. Transdermal Drug Delivery Devices : Market Analysis in the UK by application (2017-2025)

 6.7.3. Transdermal Drug Delivery Devices : Market Analysis in the UK by end user (2017-2025)

6.8. Transdermal Drug Delivery Devices : Japan Market Analysis (2017–2025)

 6.8.1. Transdermal Drug Delivery Devices : Market Analysis in Japan by type (2017-2025)

 6.8.2. Transdermal Drug Delivery Devices : Market Analysis in Japan by application (2017-2025)

 6.8.3. Transdermal Drug Delivery Devices : Market Analysis in Japan by end user (2017-2025)

7. Market Drivers

8. Market Barriers

9. Industry Trends

10. KOL’s Views

11. Analyst Views

12. PEST Analysis

13. Appendix

13.1. Bibliography

13.2. Report Methodology

14. DelveInsight Capabilities

15. Disclaimer

16. About DelveInsight

List of Table

 Table 1: Competitive Analysis

Table 2: Transdermal Drug Delivery Devices : Market Analysis in the 7MM (2017–2025)

Table 3: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by type (2017–2025)

Table 4: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by application (2017–2025)

Table 5: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by end user (2017–2025)

Table 6: Transdermal Drug Delivery Devices : United States Market Analysis (2017–2025)

Table 7: Transdermal Drug Delivery Devices : Market Analysis in the US by type (2017-2025)

Table 8: Transdermal Drug Delivery Devices : Market Analysis in the US by application (2017-2025)

Table 9: Transdermal Drug Delivery Devices : Market Analysis in the US by end user (2017-2025)

Table 10: Transdermal Drug Delivery Devices : Germany Market Analysis (2017–2025)

Table 11: Transdermal Drug Delivery Devices : Market Analysis in Germany by type (2017-2025)

Table 12: Transdermal Drug Delivery Devices : Market Analysis in Germany by application (2017-2025)

Table 13: Transdermal Drug Delivery Devices : Market Analysis in Germany by end user (2017-2025)

Table 14: Transdermal Drug Delivery Devices : France Market Analysis (2017–2025)

Table 15: Transdermal Drug Delivery Devices : Market Analysis in France by type (2017-2025)

Table 16: Transdermal Drug Delivery Devices : Market Analysis in France by application (2017-2025)

Table 17: Transdermal Drug Delivery Devices : Market Analysis in France by end user (2017-2025)

Table 18: Transdermal Drug Delivery Devices : Italy Market Analysis (2017–2025)

Table 19: Transdermal Drug Delivery Devices : Market Analysis in Italy by type (2017-2025)

Table 20: Transdermal Drug Delivery Devices : Market Analysis in Italy by application (2017-2025)

Table 21: Transdermal Drug Delivery Devices : Market Analysis in Italy by end user (2017-2025)

Table 22: Transdermal Drug Delivery Devices : Spain Market Analysis (2017–2025)

Table 23: Transdermal Drug Delivery Devices : Market Analysis in Spain by type (2017-2025)

Table 24: Transdermal Drug Delivery Devices : Market Analysis in Spain by application (2017-2025)

Table 25: Transdermal Drug Delivery Devices : Market Analysis in Spain by end user (2017-2025)

Table 26: Transdermal Drug Delivery Devices : United Kingdom Market Analysis (2017–2025)

Table 27: Transdermal Drug Delivery Devices : Market Analysis in the UK by type (2017-2025)

Table 28: Transdermal Drug Delivery Devices : Market Analysis in the UK by application (2017-2025)

Table 29: Transdermal Drug Delivery Devices : Market Analysis in the UK by end user (2017-2025)

Table 30: Transdermal Drug Delivery Devices : Japan Market Analysis (2017–2025)

Table 31: Transdermal Drug Delivery Devices : Market Analysis in Japan by type (2017-2025)

Table 32: Transdermal Drug Delivery Devices : Market Analysis in Japan by application (2017-2025)

Table 33: Transdermal Drug Delivery Devices : Market Analysis in Japan by end user (2017-2025)

List of Figures

 Figure 1: Competitive Analysis

Figure 2: Transdermal Drug Delivery Devices : Market Analysis in the 7MM (2017–2025)

Figure 3: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by type (2017–2025)

Figure 4: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by application (2017–2025)

Figure 5: Transdermal Drug Delivery Devices : Market Analysis in the 7MM by end user (2017–2025)

Figure 6: Transdermal Drug Delivery Devices : United States Market Analysis (2017–2025)

Figure 7: Transdermal Drug Delivery Devices : Market Analysis in the US by type (2017-2025)

Figure 8: Transdermal Drug Delivery Devices : Market Analysis in the US by application (2017-2025)

Figure 9: Transdermal Drug Delivery Devices : Market Analysis in the US by end user (2017-2025)

Figure 10: Transdermal Drug Delivery Devices : Germany Market Analysis (2017–2025)

Figure 11: Transdermal Drug Delivery Devices : Market Analysis in Germany by type (2017-2025)

Figure 12: Transdermal Drug Delivery Devices : Market Analysis in Germany by application (2017-2025)

Figure 13: Transdermal Drug Delivery Devices : Market Analysis in Germany by end user (2017-2025)

Figure 14: Transdermal Drug Delivery Devices : France Market Analysis (2017–2025)

Figure 15: Transdermal Drug Delivery Devices : Market Analysis in France by type (2017-2025)

Figure 16: Transdermal Drug Delivery Devices : Market Analysis in France by application (2017-2025)

Figure 17: Transdermal Drug Delivery Devices : Market Analysis in France by end user (2017-2025)

Figure 18: Transdermal Drug Delivery Devices : Italy Market Analysis (2017–2025)

Figure 19: Transdermal Drug Delivery Devices : Market Analysis in Italy by type (2017-2025)

Figure 20: Transdermal Drug Delivery Devices : Market Analysis in Italy by application (2017-2025)

Figure 21: Transdermal Drug Delivery Devices : Market Analysis in Italy by end user (2017-2025)

Figure 22: Transdermal Drug Delivery Devices : Spain Market Analysis (2017–2025)

Figure 23: Transdermal Drug Delivery Devices : Market Analysis in Spain by type (2017-2025)

Figure 24: Transdermal Drug Delivery Devices : Market Analysis in Spain by application (2017-2025)

Figure 25: Transdermal Drug Delivery Devices : Market Analysis in Spain by end user (2017-2025)

Figure 26: Transdermal Drug Delivery Devices : United Kingdom Market Analysis (2017–2025)

Figure 27: Transdermal Drug Delivery Devices : Market Analysis in the UK by type (2017-2025)

Figure 28: Transdermal Drug Delivery Devices : Market Analysis in the UK by application (2017-2025)

Figure 29: Transdermal Drug Delivery Devices : Market Analysis in the UK by end user (2017-2025)

Figure 30: Transdermal Drug Delivery Devices : Japan Market Analysis (2017–2025)

Figure 31: Transdermal Drug Delivery Devices : Market Analysis in Japan by type (2017-2025)

Figure 32: Transdermal Drug Delivery Devices : Market Analysis in Japan by application (2017-2025)

Figure 33: Transdermal Drug Delivery Devices : Market Analysis in Japan by end user (2017-2025)

Figure 34: Market Drivers

Figure 35: Market Barriers

Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

  • Tags:
  • Transdermal Drug Delivery Devices
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...

Forward to Friend

Need A Quote